S&P Global Ratings anticipates that ModivCare will fall short of its previous expectations for 2024 and 2025, leading to ongoing cash flow deficits. The company’s reliance on normalized utilization ...

Reddit shares gained 3.5% after-hours Tuesday following Piper Sandler’s recognition of a new feature that streamlines ad campaign imports from Meta Platforms Inc (NASDAQ:META).’s ads manager. The ...

F5 was up more than 12% in recent afterhours trading following the report. For the three months ended Dec. 31, the company reported adjusted earnings of $3.84 per diluted share on revenue of $766 ...

On Tuesday, the White House announced a new initiative to encourage federal workers who are reluctant to return to office ...

Shares of Skyworks Solutions (NASDAQ: SWKS) climbed 3.5% while Cirrus Logic (NASDAQ: CRUS) saw a 2% increase following a robust earnings report from fellow Apple ...

NVIDIA (NASDAQ: NVDA) shares bounced back strongly Tuesday following Monday’s DeepSeek-related sell-off, which whipped out a ...

Investing.com -- Steven Cohen, CEO of Point72, has expressed his expectation that markets could reach their peak within the next few months if this hasn’t occurred already, according to headlines from ...

Leerink, which maintains an ’outperform’ rating at $69 price target on TECX, expressed in a client note that the ...

Investing.com -- Shares of Alibaba (NYSE: NYSE: BABA) climbed 2.8% as the company’s latest AI model, Qwen2.5-Max, garnered ...

The FDA’s approval is based on the results of the FLOW phase 3b kidney outcomes trial. The trial revealed that Ozempic® 1 mg significantly lowered the relative risk of worsening kidney disease, kidney ...

"Around 70% of the [BofA] Hedge Funds’ USD position built over Q4 and around 75% via SDR FX options remain, in line with the ...

Investing.com -- In a recent development, the CEO of OpenAI, Sam Altman, has hinted at an exciting upcoming phase of ...